Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index

Sponsor
Chi-Ming Chu (Other)
Overall Status
Recruiting
CT.gov ID
NCT05080023
Collaborator
Dr. Chiang, Shang-lin (Other), Dr. Liang-Cheng Chen (Other)
10
5
21.3
2
0.1

Study Details

Study Description

Brief Summary

Regular exercise can prevent cardiovascular disease, but there is also a risk of sudden cardiac death. Exercise-related sudden death often occurs unconsciously and there is no relevant monitoring mechanism. The patent of the Cardiac Force Index (CFI), invented by Professor Chu, is a method to detect the state of cardiac motion. Recent studies have confirmed Enhanced External Counterpulsation (EECP) can increase cardiopulmonary fitness and maximal oxygen consumption. Our aim is to investigate the differences and effects of CFI between two groups with and without 4 weeks of EECP intervention, therefore, to find out the relationship between CFI and maximum oxygen consumption (VO2max).

Methods: A pre and post-test control group was designed. A total of 53 military students (33 males and 20 females) were recruited and divided into intervention and control groups. A 2000-meter running and maximum oxygen consumption tests were performed pre and post-test. The intervention group was conducted a 4 week (3 times per week/30 minutes) EECP intervention.

Condition or Disease Intervention/Treatment Phase
  • Device: Enhanced External Counterpulsation (EECP)

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
10 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index
Anticipated Study Start Date :
Feb 22, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Enhanced External Counterpulsation (EECP) on cardiac force index [4 weeks]

    Enhanced External Counterpulsation (EECP) on cardiac force index

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • can walk.
Exclusion Criteria:
  • disabilities.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Local Clinics Hualien City Taiwan
2 Local Clinics Kaohsiung Taiwan
3 Local Clinics Taichung Taiwan
4 National Defense Medical Center Taipei Taiwan 114
5 Local Clinics Taoyuan Taiwan

Sponsors and Collaborators

  • Chi-Ming Chu
  • Dr. Chiang, Shang-lin
  • Dr. Liang-Cheng Chen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Chi-Ming Chu, Prof. Dr., National Defense Medical Center, Taiwan
ClinicalTrials.gov Identifier:
NCT05080023
Other Study ID Numbers:
  • 1-104-05-147
First Posted:
Oct 15, 2021
Last Update Posted:
Feb 23, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Keywords provided by Chi-Ming Chu, Prof. Dr., National Defense Medical Center, Taiwan

Study Results

No Results Posted as of Feb 23, 2022